Incretin mimetic drugs are often prescribed for Type 2 Diabetes to help control blood sugar levels in patients by increasing insulin and decrease sugars that are made in the liver. Bydureon, Byetta, Janumet, Januvia, Jentadueto, Juvisync, Kazano, Nesina, Onglyza, Oseni, and Victoza are among the most commonly prescribed incretin drugs.
Although the FDA has approved these drugs, serious side effects are known to occur to users.
Incretin drugs have been reported to cause pancreatitis and pancreatic cancer. Pancreatitis is the inflammation or swelling of the pancreas. According to a 2011 report published in Gastroenterology, a patient’s risk for developing pancreatitis increases six-fold when taking Januvia. The condition can develop within less than two months and can be fatal. Pancreatitis can also lead to pancreatic cancer.
Pancreatic cancer can develop without symptoms, making it hard for doctors to diagnose the disease before it is too late. According to the 2011 Gastroenterology study, pancreatic cancer cases increased almost three-fold in patients that used both and Januvia.
Your Legal Options
Hundreds of pancreatitis and pancreatic cancer cases due to Januvia use have been reported around the country. Many patients and their families have filed lawsuits against the makers of the drug for failing to warn about side effects. It has also been claimed that, despite the known dangers, the manufacturers continued to market and sell the defective drugs to the public.